Linking Nicotinic Activation with Skin Innate Immunity and Atopic Dermatitis
将烟碱激活与皮肤先天免疫和特应性皮炎联系起来
基本信息
- 批准号:8298081
- 负责人:
- 金额:$ 33.64万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-05-01 至 2017-04-30
- 项目状态:已结题
- 来源:
- 关键词:AcetylcholineAddressAdvanced DevelopmentAgonistAnti-Inflammatory AgentsAnti-inflammatoryAntibioticsAreaAtopic DermatitisBacteriaBacterial InfectionsBiochemicalBiological ModelsCellsCharacteristicsChromogranin AClinicalCutaneousDataDefectDevelopmentDiseaseDisease ProgressionEconomic BurdenEnvironmentEpidermisEpithelialFailureFunctional disorderGoalsHealthHomeostasisHost DefenseHumanImmuneImmune responseImmunosuppressionIn VitroIndividualInfectionInflammationInflammatoryInjuryKnowledgeLinkMeasuresMediatingMicrobeMissionModalityMolecularMulti-Drug ResistanceMusNatural ImmunityNeurosecretory SystemsNicotinic ReceptorsPathogenesisPathway interactionsPatientsPlayPredispositionProcessProductionProteinsProteomicsPublic HealthRegimenRegulationRelative (related person)ResearchResistanceRoleSignal TransductionSkinStaphylococcus aureusStressSymptomsSystemTechniquesTestingTherapeutic InterventionTissuesWorkantimicrobialantimicrobial peptidebasebiological adaptation to stresscathelicidincholinergicchromogranin A (344-364)clinically relevanteffective therapyimprovedin vivoinnovationkeratinocytemicrobialmicroorganismneuroimmunologynovelrelating to nervous systemresponseskin disordersocial
项目摘要
DESCRIPTION (provided by applicant): An important breach exists in our understanding of how the negative regulation of antimicrobial peptides (AMPs) leads to the clinical symptoms associated with skin disease. The persistent lack of knowledge in this area of research signifies an important challenge to develop improved therapies for cutaneous infection and disease. The long-term goal is to identify how acetylcholine nicotinic receptor (nAChR) activation suppresses AMP expression and activity, and relate these changes in AMP regulation to the causal treatment of human skin diseases associated with AMP dysregulation. The objective of the proposed research is to identify the nAChR subtype(s) involved in AMP suppression in keratinocytes, evaluate the AMP profile altered by nAChR activation, and link this mechanism to the pathogenesis of Atopic Dermatitis (AD). Our hypothesis is that excess nAChR activation in keratinocytes impairs the normal processing and function of cutaneous AMPs, which contributes to the pathogenesis of AD. Our hypothesis was formulated based on preliminary data establishing that nAChR activation significantly reduced AMP activity and the resistance to cutaneous infection. Patients with AD develop a compromised skin barrier, which includes decreased AMP expression thought to precipitate inflammation and infection. Stress likely exacerbates the clinical manifestations of AD by increasing epidermal ACh and, consequently, nAChR activation to compromise normal AMP regulation and microbial susceptibility. Our rationale for these studies is that most research has focused on the positive regulation of AMPs to increase their expression and activity, yet identifying those molecules that inhibit or diminish
AMP activity is critical to develop better clinical remedies to ameliorate the symptoms associated with AD and other inflammatory skin diseases. Driven by compelling preliminary data, our hypothesis will be evaluated by addressing three Specific Aims: 1) Identify which nAChR subtypes are involved in AMP suppression and identify the AMP profile in primary normal human epidermal keratinocytes (NHEKs) in vitro; 2) Determine the role of nAChR activation in the AMP response to infection in vivo; 3) Link mechanisms of nAChR signaling to the pathogenesis of AD. For Aim 1, NHEKs will be stimulated with nAChR agonists and antagonists to assess known AMPs and identify new antimicrobial molecules using established biochemical techniques. Aim 2 will use mice with altered states of nAChR activation to analyze the AMP response to infection using established proteomic approaches. Aim 3 will demonstrate that nAChR activation participates in the suppression of the AMP response to infection in skin from AD patients using molecular approaches. Our approach is innovative because it utilizes novel proteomic and molecular techniques to further define how nAChR activation influences the epidermal AMP response to infection. The proposed studies are significant because they are anticipated to identify the major nAChR signaling mechanism that negatively regulates AMP activity in skin, and identify alternative pathways for disease progression.
PUBLIC HEALTH RELEVANCE: The proposed studies are directly relevant to improving overall human health given that the identification of alternative pathways for disease progression will ultimately impart new targets for preventative and therapeutic interventions for AD and other dermatoses associated with AMP dysregulation. Understanding how the neural system regulates local cutaneous immune responses will disseminate this knowledge to other areas of inflammatory disease research to improve treatment modalities and preventative measures. Ultimately, the proposed research is relevant to the part of the NIH's mission that intends to reduce both the economical and social burdens, and promote the development of more effective treatments to treat cutaneous infection and inflammatory diseases, ultimately enhancing the quality of global public health.
描述(由申请人提供):我们对抗菌肽(amp)的负调控如何导致与皮肤病相关的临床症状的理解存在一个重要的缺口。在这方面的研究知识的持续缺乏意味着一个重要的挑战,以开发改进的治疗皮肤感染和疾病。长期目标是确定乙酰胆碱烟碱受体(nAChR)激活如何抑制AMP的表达和活性,并将AMP调节的这些变化与AMP失调相关的人类皮肤病的因果治疗联系起来。本研究的目的是确定角化细胞中参与AMP抑制的nAChR亚型,评估nAChR激活改变的AMP谱,并将该机制与特应性皮炎(AD)的发病机制联系起来。我们的假设是,角化细胞中过量的nAChR激活会损害皮肤amp的正常加工和功能,从而导致AD的发病。我们的假设是基于初步数据,即nAChR激活显著降低AMP活性和对皮肤感染的抵抗力。AD患者的皮肤屏障受损,包括AMP表达减少,这被认为会导致炎症和感染。应激可能通过增加表皮乙酰胆碱和nAChR的激活从而破坏正常的AMP调节和微生物敏感性,从而加剧AD的临床表现。我们进行这些研究的基本原理是,大多数研究都集中在amp的正调控上,以增加其表达和活性,但识别那些抑制或减少的分子
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Katherine Amanda Radek其他文献
Katherine Amanda Radek的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Katherine Amanda Radek', 18)}}的其他基金
Targeting the CHRNA7 Receptor to Modulate Wound Antimicrobial Responses
靶向 CHRNA7 受体调节伤口抗菌反应
- 批准号:
9896364 - 财政年份:2020
- 资助金额:
$ 33.64万 - 项目类别:
Linking Nicotinic Activation with Skin Innate Immunity and Atopic Dermatitis
将烟碱激活与皮肤先天免疫和特应性皮炎联系起来
- 批准号:
8460051 - 财政年份:2012
- 资助金额:
$ 33.64万 - 项目类别:
Linking Nicotinic Activation with Skin Innate Immunity and Atopic Dermatitis
将烟碱激活与皮肤先天免疫和特应性皮炎联系起来
- 批准号:
8836391 - 财政年份:2012
- 资助金额:
$ 33.64万 - 项目类别:
Linking Nicotinic Activation with Skin Innate Immunity and Atopic Dermatitis
将烟碱激活与皮肤先天免疫和特应性皮炎联系起来
- 批准号:
8655796 - 财政年份:2012
- 资助金额:
$ 33.64万 - 项目类别:
Dermatan sulfate and its role in tissue repair
硫酸皮肤素及其在组织修复中的作用
- 批准号:
7405689 - 财政年份:2008
- 资助金额:
$ 33.64万 - 项目类别:
Dermatan sulfate and its role in tissue repair
硫酸皮肤素及其在组织修复中的作用
- 批准号:
7612708 - 财政年份:2008
- 资助金额:
$ 33.64万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 33.64万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 33.64万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 33.64万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 33.64万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 33.64万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 33.64万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 33.64万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 33.64万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 33.64万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 33.64万 - 项目类别:
Research Grant